Need for an addendum on the clinical investigation of medicinal products intended for treatment of glucocorticoid-induced osteoporosis - Scientific guideline

This document reflects the need for an addendum on glucocorticoid-induced osteoporosis to the guideline on the clinical investigation of medicinal products used in the treatment of osteoarthritis.

Keywords: Osteoporosis, glucocorticoids, secondary osteoporosis, postmenopausal osteoporosis, endpoints

Current effective version

Concept paper on the need for an addendum on the clinical investigation of medicinal products intended for treatment of glucocorticoid-induced osteoporosis

Draft: consultation closedConsultation dates: 20/01/2010 to 30/04/2010Reference Number: EMA/CHMP/EWP/15912/2010